PolyPeptide Group AG

Lobbying Governance & Transparency

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Lobbying Governance
Overall Assessment Analysis Score
None PolyPeptide has established comprehensive governance structures for ESG and climate-related risk management, with its “Board of Directors oversee[ing] climate-related risks and opportunities as defined in the Climate Report” and thematic oversight for sustainability matters assigned to committees such as the Remuneration and Nomination Committee, the Audit and Risk Committee, and the Innovation and Technology Committee. Operational implementation is delegated to the Executive Committee with support from the ESG Steering Committee and a cross-functional Green Steering Committee, where “the Director Global EHS develops and deploys the transition plan, oversees GHG emissions assessments, and updates progress toward science-based targets” while ensuring “clear reporting mechanisms for tracking and managing climate-related matters.” However, we found no evidence of any dedicated lobbying governance process, as there is no mention of oversight of lobbying activities, alignment of direct or indirect lobbying with the company’s climate positions, or any monitoring or management procedures for lobbying engagements.

View Sources

E
Lobbying Transparency
Overall Assessment Analysis Score
None No evidence found

E